The US warns that breast cancer bags are rare and hard to cure

The US Food and Drug Administration confirms that breast augmentation bags can cause a rare and hard-to-treat form of cancer.

359 women complained to the US Food and Drug Administration (FDA) about the sillicon breast augmentation bag causing non-Hodgin lymphoma, related to degenerative large lymphocytes (ALCL).

This is a rare and difficult form of lymphoma.

As of February 1, 2017, 9 of the women who complain have died.

FDA warnings marked a major victory for American medical researchers.

Six years ago, the World Health Organization (WHO) warned for the first time the link between sillicon breast augmentation bags and cancer risk.

Picture 1 of The US warns that breast cancer bags are rare and hard to cure
FDA confirmed a clear link between silicon breast augmentation bags and a rare form of cancer.(Photo: Daily Mail).

Last year, France became the first country to acknowledge a clear link between silicon breast augmentation bags and cancer risk.

The government requires manufacturers to demonstrate the safety of the product, otherwise they are banned from circulation.

The UK Drug and Health Care Administration is still analyzing reports from US and French officials, so they have not spoken.

Breast augmentation is the second most popular plastic surgery in the US, with more than 300,000 cases a year.

Regulatory authorities reassure patients that they can easily treat cancer with chemotherapy or radiation, if they remove their breasts from their bodies.

"All the information we have gathered to date has shown that women with breast augmentation in breast bags face the risk of getting low levels of ALCL, but gradually increase compared to women who do not breast augmentation with silicon bags" - FDA said on March 21.

Some researchers believe that bacteria attach to the outer part of the silicon bag during surgery.

The presence of bacteria causes the immune system to change - the factor that causes cancer cells. However, no research has proven that hypothesis.

In most cases of ALCL infection, women can successfully treat with surgery. But some people may need chemotherapy or radiation therapy.